sl 84.0418 has been researched along with Alloxan Diabetes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angel, I; Burcelin, R; Girard, J; Langer, SZ; Prouteau, M | 1 |
Angel, I; Coste, A; Eon, MT; Guillot, E | 1 |
2 other study(ies) available for sl 84.0418 and Alloxan Diabetes
Article | Year |
---|---|
Normalization of insulin secretion by a selective alpha 2-adrenoceptor antagonist restores GLUT-4 glucose transporter expression in adipose tissue of type II diabetic rats.
Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic alpha-Antagonists; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Gene Expression; Glucose Tolerance Test; Glucose Transporter Type 4; Indoles; Insulin; Insulin Secretion; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Myocardium; Pyrroles; Rats; Rats, Wistar; RNA, Messenger | 1996 |
Mechanisms of the hypoglycemic effects of the alpha2-adrenoceptor antagonists SL84.0418 and deriglidole.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Glucose; Chlorisondamine; Diabetes Mellitus, Experimental; Diazoxide; Female; Glucose Tolerance Test; Hypoglycemic Agents; Imidazoles; Indoles; Insulin; Insulin Antagonists; Insulin Secretion; Male; Mice; Norepinephrine; Propranolol; Pyrroles; Rats; Rats, Sprague-Dawley; Species Specificity | 1998 |